Niranjan Kameswaran | Senior Vice President of Strategy |
Mark Iwicki | Chairman, President & Chief Executive Officer |
Todd Bazemore | Chief Operating Officer |
Mary Reumuth | Chief Financial Officer |
Kim Brazzell | Chief Medical Officer |
Chris Neyor | JPMorgan |
François Brisebois | Oppenheimer |
Tazeen Ahmad | Bank of America |
Chris Howerton | Jefferies |
Yi Chen | H.C. Wainwright |
Tim Chiang | Northland Capital |
Good morning, and welcome to Kala Pharmaceuticals' Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following managements prepared remarks, a Q&A session will be held.
As a reminder, this call is being recorded. I would now like to turn the conference over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals.